Research

Did you know that EAN members can submit survey proposals to explore a specific area of scientific interest? The EAN offers scientific support throughout the whole process including survey design, set-up, and dissemination.

A retrospective, multicentre, cross-sectional study aiming to evaluate the performance of cortical lesions and the central vein sign in differentiating multiple sclerosis from other conditions with brain white matter lesions.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for January 2024.

Application is currently open for this year’s David Marsden Award with a deadline for submissions of 29 February 2024.

This study presents the results of a clinical trial investigating whether apixaban, compared to aspirin, would be associated with reduced risk of stroke or systemic embolism, with a tolerably low risk of major bleeding.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for December 2023.

Our Paper of the Month for November is a meta-analysis investigating the safety and efficacy of oral anticoagulation for prevention of major cardiovascular events in patients with atrial fibrillation and previous spontaneous intracranial haemorrhage.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for November 2023.

Representatives of the EAN Guideline Production Group participated in the GIN 2023 conference in Glasgow, presenting the EAN's Guideline Prioritisation Process.

Prof. Claudio Bassetti and Dr Marina Τüzün presented the design of the Burden of Sleep/Wake Disorders: Excessive Daytime Sleepiness and Insomnia project and the initial results of the pilot study currently taking place in Bern.

Our Paper of the Month for October 2023 is a multicentre, prospective, randomised clinical trial investigating whether transdermal nicotine may have a disease-modifying effect in early, therapy-naïve Parkinson's disease.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for October 2023.

The European Medicines Agency (EMA) is looking for new data partners to collaborate with DARWIN EU® - the Data Analysis and Real-World Interrogation Network.

The EAN is pleased to announce the creation of a new Coordinating Panel on Functional Neurological Disorders. All EAN Individual Members with an interest in this field are encouraged to apply!

Our paper of the month presents the results of a randomised trial assessing AXER-204, a soluble decoy fragment of NgR1 able to block the action of three inhibitors of the axonal growth in individuals with chronic traumatic cervical SCI.